{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:46Z","timestamp":1759336246117},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[1985,1]]},"DOI":"10.1007\/bf00442138","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T03:46:12Z","timestamp":1100231172000},"page":"198-202","source":"Crossref","is-referenced-by-count":39,"title":["Oral BVDU treatment of varicella and zoster in children with cancer"],"prefix":"10.1007","volume":"143","author":[{"given":"Y.","family":"Benoit","sequence":"first","affiliation":[]},{"given":"G.","family":"Laureys","sequence":"additional","affiliation":[]},{"given":"M. -J.","family":"Delbeke","sequence":"additional","affiliation":[]},{"given":"E.","family":"De Clercq","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1073\/pnas.78.5.2698","volume":"78","author":"HS Allaudeen","year":"1981","unstructured":"Allaudeen HS, Kozarich JW, Bertino JR, De Clercq E (1981) On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2?-deoxyuridine. Proc Natl Acad Sci USA 78:2698?2702","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0021-9258(19)68234-7","volume":"257","author":"HS Allaudeen","year":"1982","unstructured":"Allaudeen HS, Chen MS, Lee JJ, De Clercq E, Prusoff WH (1982) Incorporation of E-5-(2-halovinyl)-2?-deoxyuridines into deoxyribonucleic acids of herpes simplex virus type 1-infected cells. J Biol Chem 257:603?606","journal-title":"J Biol Chem"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-3476(84)80611-3","volume":"104","author":"HH Balfour Jr","year":"1984","unstructured":"Balfour HH Jr (1984) Intravenous acyclovir therapy for varicella in immunocompromised children. J Pediatr 104:134?136","journal-title":"J Pediatr"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198306163082404","volume":"308","author":"HH Balfour Jr","year":"1983","unstructured":"Balfour HH Jr, Bean B, Laskin OL, Ambinder RF, Meyers JD, Wade JC, Zaia JA, Aeppli D, Kirk LE, Segreti AC, Keeney RE, The Burroughs Wellcome Collaborative Acyclovir Study Group (1983) Acyclovir halts progression of herpes zoster in immunocompromised patients. New Engl J Med 308:1448?1453","journal-title":"New Engl J Med"},{"issue":"Suppl B","key":"CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/12.suppl_B.169","volume":"12","author":"HH Balfour Jr","year":"1983","unstructured":"Balfour HH Jr, McMonigal KA, Bean B (1983) Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients. J Antimicrob Chemother 12 [Suppl B]:169?179","journal-title":"J Antimicrob Chemother"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(82)91090-X","volume":"II","author":"B Bean","year":"1982","unstructured":"Bean B, Braun C, Balfour HH Jr (1982) Acyclovir therapy for acute herpes zoster. Lancet II:118?121","journal-title":"Lancet"},{"key":"CR7","first-page":"230","volume":"20","author":"Y-C Cheng","year":"1981","unstructured":"Cheng Y-C, Dutschman G, De Clercq E, Jones AS, Rahim SG, Verhelst G, Walker RT (1981) Differential affinities of 5-(2-halogenovinyl)-2?-deoxyuridines for deoxythymidine kinases of various origins. Mol Pharmacol 20:230?233","journal-title":"Mol Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4613-3804-8_6","volume-title":"Antiviral drugs and interferon: the molecular basis of their activity","author":"F Clercq De","year":"1984","unstructured":"De Clercq F (1984) BVDU [(E)-5-(2-bromovinyl)-2?-deoxyuridine]. In: Becker Y (ed) Antiviral drugs and interferon: the molecular basis of their activity. Martinus Nijhoff Publishing, Boston, pp 89?104"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/AAC.16.2.234","volume":"16","author":"E Clercq De","year":"1979","unstructured":"De Clercq E, Descamps J, De Somer P, Barr PJ, Jones AS, Walker RT (1979) Pharmacokinetics of E-5-(2-bromovinyl)-2?-deoxyuridine in mice. Antimicrob Agents Chemother 16:234?236","journal-title":"Antimicrob Agents Chemother"},{"key":"CR10","doi-asserted-by":"crossref","unstructured":"De Clercq E, Degreef H, Wildiers J, De Jonge G, Drochmans A, Descamps J, De Somer P (1980) Oral (E)-5-(2-bromovinyl)-2?-deoxyuridine in severe herpes zoster. Br Med J 281?1178","DOI":"10.1136\/bmj.281.6249.1178"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1073\/pnas.76.6.2947","volume":"76","author":"E Clercq De","year":"1979","unstructured":"De Clercq E, Descamps J, De Somer P, Barr PJ, Jones AS, Walker RT (1979) (E)-5-(2-Bromovinyl)-2?-deoxyuridine: a potent and selective antiherpes agent. Proc Natl Acad Sci USA 76:2947?2951","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/infdis\/141.5.563","volume":"141","author":"E Clercq De","year":"1980","unstructured":"De Clercq E, Descamps J, Verhelst G, Walker RT, Jones AS, Torrence PF, Shugar D (1980) Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis 141:563?574","journal-title":"J Infect Dis"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-95-5-549","volume":"95","author":"R Dolin","year":"1981","unstructured":"Dolin R, Reichman RC, Mazur MH, Whitley RJ (1981) Herpes zoster varicella infections in immunosuppressed patients. Ann Intern Med 95:549?555","journal-title":"Ann Intern Med"},{"key":"CR14","first-page":"178","volume":"126","author":"S Feldman","year":"1973","unstructured":"Feldman S, Hughes WT, Kim HY (1973) Herpes zoster in children with cancer. Am J Dis Child 126:178?184","journal-title":"Am J Dis Child"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1542\/peds.56.3.388","volume":"56","author":"S Feldman","year":"1975","unstructured":"Feldman S, Hughes WT, Daniel CB (1975) Varicella in children with cancer. Seventy seven cases. Pediatrics 56:388?397","journal-title":"Pediatrics"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0163-4453(82)92886-9","volume":"5","author":"JM Gould","year":"1982","unstructured":"Gould JM, Chessells JM, Marshall WC, McKendrick GDW (1982) Acyclovir in herpesvirus infections in children: experience in an open study with particular reference to safety. J Infect 5: 283?289","journal-title":"J Infect"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJM198310203091607","volume":"309","author":"MS Hirsch","year":"1983","unstructured":"Hirsch MS, Schooley RT (1983) Treatment of herpesvirus infections. New Engl J Med 309:963?970; 309:1034?1039","journal-title":"New Engl J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0021-9258(18)33118-1","volume":"258","author":"WR Mancini","year":"1983","unstructured":"Mancini WR, De Clercq E, Prusoff WH (1983) The relationship between incorporation of E-5-(2-bromovinyl)-2?-deoxyuridine into herpes simplex virus type 1 DNA with virus infectivity and DNA integrity. J Biol Chem 258:792?795","journal-title":"J Biol Chem"},{"key":"CR19","first-page":"49","volume":"193","author":"PC Maudgal","year":"1981","unstructured":"Maudgal PC, Dralands L, Lamberts L, De Clercq E, Descamps J, Missotten L (1981) Preliminary results of oral BVDU treatment of herpes zoster ophthalmicus. Bull Soc Belge Ophtalmol 193:49?56","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-3542(84)90033-0","volume":"4","author":"PC Maudgal","year":"1984","unstructured":"Maudgal PC, De Clercq E, Missotten L (1984) Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections. Antiviral Res 4:281?291","journal-title":"Antiviral Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00455033","volume":"216","author":"PC Maudgal","year":"1981","unstructured":"Maudgal PC, Missotten L, De Clercq E, Descamps J, De Meuter E (1981) Efficacy of (E)-5-(2-bromovinyl)-2?-deoxyuridine in the topical treatment of herpes simplex keratitis. Albrecht von Graefes Arch Klin Ophthalmol 216:261?268","journal-title":"Albrecht von Graefes Arch Klin Ophthalmol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(81)91102-8","volume":"II","author":"NA Peterslund","year":"1981","unstructured":"Peterslund NA, Sever-Hansen K, Ipsen J, Esmann V, Schonheyder H, Juhl H (1981) Acyclovir in herpes zoster. Lancet II:827?830","journal-title":"Lancet"},{"key":"CR23","first-page":"95","volume":"40","author":"D Peyramond","year":"1983","unstructured":"Peyramond D, Demoyel GA, Philip T, Souillet G, Philippe N, Bertrand JL, Bertoye A (1983) Varicella-zoster virus infections in immunosuppressed children. Acyclovir therapy and controls. Arch Fr Pediatr 40:95?99","journal-title":"Arch Fr Pediatr"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0022-3476(82)80725-7","volume":"101","author":"CG Prober","year":"1982","unstructured":"Prober CG, Kirk LE, Keeney RE (1982) Acyclovir therapy of chickenpox in immunosuppressed children?a collaborative study. J Pediatr 101:622?625","journal-title":"J Pediatr"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(79)92281-5","volume":"II","author":"PJ Selby","year":"1979","unstructured":"Selby PJ, Powles RL, Jameson B, Kay HEM, Watson JG, Thornton R, Morgenstern G, Clink HM, McElwain TJ, Prentice HG, Corringham R, Ross MG, Hoffbrand AV, Brigden D (1979) Parenteral acyclovir therapy for herpesivirus infections in man. Lancet II:1267?1270","journal-title":"Lancet"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/147.3.576","volume":"147","author":"S Shigeta","year":"1983","unstructured":"Shigeta S, Yokota T, Iwabuchi T, Baba M, Konno K, Ogata M, De Clercq E (1983) Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. J Infect Dis 147:576?584","journal-title":"J Infect Dis"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/AAC.20.3.291","volume":"20","author":"KF Soike","year":"1981","unstructured":"Soike KF, Felsenfeld AD, Gerone PJ (1981) Acyclovir treatment of experimental simian varicella infection of monkeys. Antimicrob Agents Chemother 20:291?297","journal-title":"Antimicrob Agents Chemother"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0166-3542(81)90024-3","volume":"1","author":"KF Soike","year":"1981","unstructured":"Soike KF, Gibson S, Gerone PJ (1981) Inhibition of simian varicella virus infection of African green monkeys by (E)-5-(2-bromovinyl)-2?-deoxyuridine (BVDU). Antiviral Res 1:325?337","journal-title":"Antiviral Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(81)90725-X","volume":"I","author":"MH Well-Sipman Van","year":"1981","unstructured":"Van Well-Sipman MH, van der Meer JWM, de Koning J, Versteeg J (1981) Severe atypical recurrent varicella in childhood leukaemia. Lancet I:147?148","journal-title":"Lancet"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJM197605272942201","volume":"294","author":"RJ Whitley","year":"1976","unstructured":"Whitley RJ, Ch'ien LT, Dolin R, Galasso GJ, Alford CA Jr, Collaborative Study Group (1976) Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. New Engl J Med 294:1193?1199","journal-title":"New Engl J Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3476(82)80201-1","volume":"101","author":"R Whitley","year":"1982","unstructured":"Whitley R, Hilty M, Haynes R, Bryson Y, Connor JD, Soong S-J, Alford CA, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (1982) Vidarabine therapy of varicella in immunosuppressed patients. J Pediatr 101:125?131","journal-title":"J Pediatr"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJM198210143071602","volume":"307","author":"RJ Whitley","year":"1982","unstructured":"Whitley RJ, Soong S-J, Dolin R, Betts R, Linneman C Jr, Alford CA Jr, NIAID Collaborative Antiviral Study Group (1982) Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. New Engl J Med 307:971?975","journal-title":"New Engl J Med"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0277-5379(84)90231-1","volume":"20","author":"J Wildiers","year":"1984","unstructured":"Wildiers J, De Clercq E (1984) Oral (E)-5-(2-bromovinyl)-2?-deoxyuridine treatment of severe herpes zoster in cancer patients. Eur J Cancer Clin Oncol 20:471?476","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.23.4.593","volume":"23","author":"JR Wingard","year":"1983","unstructured":"Wingard JR, Hess AD, Stuart RK, Saral R, Burns WH (1983) Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation. Antimicrob Agents Chemother 23:593?597","journal-title":"Antimicrob Agents Chemother"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1128\/AAC.24.5.803","volume":"24","author":"AE Wittek","year":"1983","unstructured":"Wittek AE, Cohen PS, Arvin AM, Smith SD, Koropchak CM, De Clercq E (1983) Effect of (E)-5-(2-bromovinyl)-2?-deoxyuridine on proliferation of human fibroblasts, peripheral blood mononuclear cells, and granulocyte-monocyte progenitor cells in vitro. Antimicrob Agents Chemother 24:803?806","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00442138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00442138\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00442138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T05:05:25Z","timestamp":1682831125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00442138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["BF00442138"],"URL":"https:\/\/doi.org\/10.1007\/bf00442138","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]}}}